Hide metadata

dc.date.accessioned2020-02-27T15:07:05Z
dc.date.available2020-02-27T15:07:05Z
dc.date.created2019-05-15T16:02:35Z
dc.date.issued2019
dc.identifier.citationTopaz, Nadav Caugant, Dominique A Taha, Muhamed-Kheir Brynildsrud, Ola Brønstad Debech, Nadia Hong, Eva Deghmane, Ala-Eddine Ouédraogo, Rasmata Ousmane, Sani Gamougame, Kadidja Njanpop-Lafourcade, Berthe-Marie Diarra, Seydou Fox, Leanne M. Wang, Xin . Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011–2016. EBioMedicine. 2019, 41, 488-496
dc.identifier.urihttp://hdl.handle.net/10852/73367
dc.description.abstractBackground Historically, the major cause of meningococcal epidemics in the meningitis belt of sub-Saharan Africa has been Neisseria meningitidis serogroup A (NmA), but the incidence has been substantially reduced since the introduction of a serogroup A conjugate vaccine starting in 2010. We performed whole-genome sequencing on isolates collected post-2010 to assess their phylogenetic relationships and inter-country transmission. Methods A total of 716 invasive meningococcal isolates collected between 2011 and 2016 from 11 meningitis belt countries were whole-genome sequenced for molecular characterization by the three WHO Collaborating Centers for Meningitis. Findings We identified three previously-reported clonal complexes (CC): CC11 (n = 434), CC181 (n = 62) and CC5 (n = 90) primarily associated with NmW, NmX, and NmA, respectively, and an emerging CC10217 (n = 126) associated with NmC. CC11 expanded throughout the meningitis belt independent of the 2000 Hajj outbreak strain, with isolates from Central African countries forming a distinct sub-lineage within this expansion. Two major sub-lineages were identified for CC181 isolates, one mainly expanding in West African countries and the other found in Chad. CC10217 isolates from the large outbreaks in Nigeria and Niger were more closely related than those from the few cases in Mali and Burkina Faso. Interpretations Whole-genome based phylogenies revealed geographically distinct strain circulation as well as inter-country transmission events. Our results stress the importance of continued meningococcal molecular surveillance in the region, as well as the development of an affordable vaccine targeting these strains.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titlePhylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011–2016en_US
dc.typeJournal articleen_US
dc.creator.authorTopaz, Nadav
dc.creator.authorCaugant, Dominique A
dc.creator.authorTaha, Muhamed-Kheir
dc.creator.authorBrynildsrud, Ola Brønstad
dc.creator.authorDebech, Nadia
dc.creator.authorHong, Eva
dc.creator.authorDeghmane, Ala-Eddine
dc.creator.authorOuédraogo, Rasmata
dc.creator.authorOusmane, Sani
dc.creator.authorGamougame, Kadidja
dc.creator.authorNjanpop-Lafourcade, Berthe-Marie
dc.creator.authorDiarra, Seydou
dc.creator.authorFox, Leanne M.
dc.creator.authorWang, Xin
cristin.unitcode185,52,14,0
cristin.unitnameAvdeling for samfunnsmedisin og global helse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1698140
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=EBioMedicine&rft.volume=41&rft.spage=488&rft.date=2019
dc.identifier.jtitleEBioMedicine
dc.identifier.volume41
dc.identifier.startpage488
dc.identifier.endpage496
dc.identifier.doihttps://doi.org/10.1016/j.ebiom.2019.02.054
dc.identifier.urnURN:NBN:no-76499
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn2352-3964
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/73367/1/Topaz_2019_Phy.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International